NDC 0338-3814 – Clindamycin phosphate
Clindamycin Phosphate 900 mg/50mL · Injection, Solution · Intravenous
Product NDC0338-3814
Product details
- Brand name
- Clindamycin phosphate
- Generic name
- Clindamycin phosphate
- Labeler
- Baxter Healthcare Company
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA208084
- Marketed since
- June 28, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Lincosamide Antibacterial
Active ingredients
- Clindamycin Phosphate 900 mg/50mL
Uses, dosage, side effects and warnings for clindamycin phosphate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-3814-24 | 24 BAG in 1 CARTON (0338-3814-24) / 50 mL in 1 BAG (0338-3814-50) | Jun 28, 2017 |
Recalls mentioning this NDC
- D-0815-2026 Sep 9, 2026 · Class II
CGMP Deviations - D-0808-2026 Sep 9, 2026 · Class II
CGMP Deviations
Other clindamycin phosphate products
- 50090-1932 Clindamycin Phosphate 10 mg/mL · Solution · A-S Medication Solutions
- 50090-5779 Clindamycin Phosphate 11.9 mg/mL · Solution · A-S Medication Solutions
- 50090-2611 Clindamycin Phosphate 10 mg/mL · Solution · A-S Medication Solutions
- 50090-6593 Clindamycin Phosphate 10 mg/mL · Solution · A-S Medication Solutions
- 50090-5958 Clindamycin Phosphate 10 mg/g · Gel · A-S Medication Solutions
- 50090-6072 Clindamycin Phosphate 10 mg/g · Gel · A-S Medication Solutions
- 62332-623 Clindamycin Phosphate 10 mg/g · Gel · Alembic Pharmaceuticals Inc.
- 46708-623 Clindamycin Phosphate 10 mg/g · Gel · Alembic Pharmaceuticals Limited
- 69238-2031 Clindamycin Phosphate 1 g/100mL · Gel · Amneal Pharmaceuticals NY LLC
- 59651-806 Clindamycin Phosphate 10 mg/g · Gel · Aurobindo Pharma Limited
- 0338-3612 Clindamycin Phosphate 600 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-3616 Clindamycin Phosphate 600 mg/50mL · Injection, Solution · Baxter Healthcare Company